Size: Decrease Font Size Increase Font Size

Medicare’s Prescription Drug Program (Part D)

The Patient Protection and Affordable Care Act (PPACA) improves the Medicare Part D Prescription Drug program. For people with Medicare and the people who serve them, this is very good news. Medicare Part D is a complicated program, and Universal American supports collaborative efforts with the federal and state governments to simplify it.

Our Position

  • The closing of the coverage gap ('donut hole') has importance. Medicare Prescription Drug plan members will receive more coverage, and there will be broader public acceptance of the Medicare Part D Prescription Drug program now that the program flaw will be fixed. Universal American believes that the gradual closing of the coverage gap will mean that more people with Medicare will take their prescriptions regularly throughout the year. This will result in longer lives and healthier people.
  • New Part D bidding rules make it easier for people with limited incomes eligible for both Medicare and Medicaid, along with other limited income members, to stay in their plans. Universal American believes this is a positive development because it reduces the number of disruptive drug-plan changes and increases consistency in drug therapies.
  • Critics claim that the Medicare Part D Prescription Drug Program is difficult for many to understand. The government has stepped up efforts to simplify Part D by making sure drug plans offered by the same Part D sponsor have meaningful differences. Universal American supports this effort but encourages the government to make these changes gradually to lessen disruptions in member drug therapies. Universal American supports efforts to simplify Part D education materials and make the program easier for members to understand.